Skip to main content
NIH funding notice RFA-CA-20-034

NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)

Closed on November 9, 2020.

Posted
August 25, 2020
Close date
November 9, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,324,490 in first-year total cost, median $634,384.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 GRB-I (M1)]7

Most frequent institutions

  1. CHILDREN'S HOSP OF PHILADELPHIA1
  2. LURIE CHILDREN'S HOSPITAL OF CHICAGO1
  3. SLOAN-KETTERING INST CAN RESEARCH1
  4. ST. JUDE CHILDREN'S RESEARCH HOSPITAL1
  5. UNIVERSITY OF NEW SOUTH WALES1
Competing awards under RFA-CA-20-034 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021In Vivo Testing of Novel Drug Combinations for Pediatric Soft Tissue Sarcomas1U01CA263969-01DYER, MICHAEL AST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN$767,363ZCA1
2021Pediatric Preclinical In Vivo Testing Center for Pediatric Sarcoma and Other Solid Tumors1U01CA263967-01DELA CRUZ, FILEMON SKUNG, ANDREW LSLOAN-KETTERING INST CAN RESEARCH, NY$749,282ZCA1
2021NCI Pediatric In Vivo Testing Program: Neuroblastoma1U01CA263957-01MOSSE, YAEL PCHILDREN'S HOSP OF PHILADELPHIA, PA$712,800ZCA1
2021In vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xenograft Models2U01CA199288-06LI, XIAONANLURIE CHILDREN'S HOSPITAL OF CHICAGO, IL$634,384ZCA1
2021A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer1U01CA263981-01HOUGHTON, PETER JKURMASHEVA, RAUSHANUNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX$600,685ZCA1
2021NCI Pediatric In Vivo Testing Program - Leukemia2U01CA199000-06LOCK, RICHARD BUNIVERSITY OF NEW SOUTH WALES$454,976ZCA1
2021Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models2U01CA199221-07GORLICK, RICHARD G.UNIVERSITY OF TX MD ANDERSON CAN CTR, TX$405,000ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-CA-20-034: NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience